2026年,药企大规模收购潮将至!

制药网
Dec 29, 2025

近年来,在众多药企遭遇优质资产短缺,想快速补收入的背景下,药企对收购的热情正持续高涨。2025年年末,药企收购更是迎来大爆发。12月24日,赛诺菲宣布与纳斯达克上市疫苗公司Dynavax Technologies Corporation达成最终协议,将以每股15.50美元现金收购其全部流通股,总股权价值约22亿美元。整个收购,预计于2026年第一季度交割。根据公开资料整理,Dynavax核心资产...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10